BeiGene AUS Pty Ltd
$3.2M 0 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Endo USA, Inc.
Endo USA, Inc. reported $3,243,181.50 across General Payments, Research, and Ownership to 10,750 physicians and teaching hospitals across 10,792 transactions.
- $3.2M Top quartile payer
- All-tracks total
- 10,792 Top quartile volume
- Transactions
- 10,750 Top 10% reach
- Recipients
- #346
- of 1,925 companies
Endo USA, Inc. reported $3,243,181.50 across all CMS Open Payments tracks (General + Research + Ownership) to 10,750 physicians and teaching hospitals in Program Year 2024 - ranking #346 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,507,200.83, averaging $301.69 per recipient.
How Endo USA, Inc.'s $3.2M all-tracks total breaks down
Endo USA, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
C
78/100
Total payments
F
40/100
Transaction volume
B
88/100
Physician reach
A
92/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer endo-usa-inc Endo USA, Inc.
$3.2M · #346/1,925 · 0.0% industry · PY2024
- TOT $3.2M
- RANK #346
- SHARE 0.0%
- TXN 10,792
- RCP 10,750
- CAT 7
- GEN $1.5M
- TOP1 12.0%
- PY 2024
Volume peers
Nearest volume peer: BeiGene AUS Pty Ltd ($3.2M)
Endo USA, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Endo USA, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Endo USA, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
127 transactions worth $421.6K make "Compensation for Services Other Than Consulting" the top general-payment category in the 7-category breakdown below, 28.0% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 7 types of general payments, Endo USA, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $421.6K - 28.0% of General Payments.
Endo USA, Inc. reports 7 general-payment categories - the top three are Compensation for Services Other Than Consulting (28.0%), Grant (25.5%), and Consulting Fee (21.4%). The remaining 4 categories make up 25.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Endo USA, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $421.6K | 127 | 28.0% |
| Grant | $383.8K | 9 | 25.5% |
| Consulting Fee | $321.8K | 73 | 21.4% |
| Food and Beverage | $286.8K | 10,238 | 19.0% |
| Travel and Lodging | $77.7K | 295 | 5.2% |
| Space Rental or Facility Fees | $15.4K | 7 | 1.0% |
| Education | $62.00 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $514,161.40 (34.1%) of $1,507,200.83 in this company's General Payments records across 4,957 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Endo USA, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
University of Miami Hospital
$181,200.00 across 1 reported transactions
- 2
Jeffrey Freid
$128,675.00 across 17 reported transactions
- 3
Damon Adamany
$81,582.66 across 74 reported transactions
- 4
University of Washington Med Ctr
$62,500.00 across 3 reported transactions
- 5
Prosper Benhaim
$60,203.74 across 21 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Endo USA, Inc. ranks #346 of 1,925 by total payments (top 18% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,418 of 1,838 by HHI (bottom 23% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Johnson & Johnson Vision Care, Inc. : $3.2M total payments, HHI 355
- MicroVention, Inc. : $3.4M total payments, HHI 355
- United Therapeutics Corporation : $4.3M total payments, HHI 355
- Dornier MedTech America, Inc : $4.3K total payments, HHI 354
- Moximed, Inc : $1.8K total payments, HHI 353
- Edwards Lifesciences Corporation : $27.8M total payments, HHI 353
- Endo USA, Inc. (this company) : $1.5M total payments, HHI 351
- Thommen Medical USA, LLC : $89.6K total payments, HHI 351
- OPKO Pharmaceuticals, LLC : $235.7K total payments, HHI 350
- Teleflex LLC : $5.6M total payments, HHI 349
- Carl Zeiss Meditec USA, Inc. : $719.3K total payments, HHI 348
- Checkpoint Surgical, Inc : $293.7K total payments, HHI 348
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Endo USA, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Endo USA, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Endo USA, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Chugai Pharmaceutical Co., Ltd.
$3.2M 133 recipients
Compare payment profiles
Phasor Health, LLC
$3.2M 0 recipients
Compare payment profiles
BioLineRx USA, Inc.
$3.3M 137 recipients
Compare payment profiles
Viseon, Inc.
$3.2M 67 recipients
Compare payment profiles
Kowa Holdings America, Inc.
$3.3M 0 recipients
Compare payment profiles
Put this to use
Endo USA, Inc. ranks #346 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Endo USA, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Endo USA, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.